Musculoskeletal Problems in Patients With COVID-19: A Review Study
Abstract
Introduction: SARS-CoV-2 is a coronavirus, primarily targets the human respiratory system and causes symptoms similar to those of pneumonia. However, these patients do not only experience respiratory problems. Those with COVID-19 infection may show various signs and symptoms, including fever, shortness of breath, dry cough, nasal congestion, sore throat, nausea, vomiting, myalgia, arthralgia, fatigue (muscular and mental), joint swelling, headache, diarrhea, as well as some musculoskeletal symptoms. Therefore, this article aimed to investigate the major musculoskeletal problems in patients with COVID-19 through a review study.
Materials and Methods: This study gathered the related published studies in PubMed, Web of Science, and Science Direct. The main keywords were “COVID-19”, “coronavirus”, and “musculoskeletal problem”.
Results: The major musculoskeletal symptoms include muscle fatigue, myalgia, arthralgia, joint swelling (reactive arthritis), and such conditions as joint limitations, tendon shortening, and muscle weakness due to prolonged bed rest. However, their prevalence rates have not been investigated systematically.
Conclusion: Our findings revealed that attention to musculoskeletal rehabilitation of patients with COVID-19 is as essential as their respiratory rehabilitation. Besides, it would be effective in reducing the physical complications of hospitalization, returning to independence and functional activities, and improving the quality of the patients’ life.
Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. Journal of Medical Virology. 2020; 92(4):418-23. [DOI:10.1002/jmv.25681] [PMID] [PMCID]
Zhao Sh, Lin Q, Ran J, Musa SS, Yang G, Wang W, et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak. International Journal of Infectious Diseases. 2020; 92:214-7. [DOI:10.1016/j.ijid.2020.01.050] [PMID] [PMCID]
Park M, Cook AR, Lim JT, Sun Y, Dickens BL. A systematic review of COVID-19 epidemiology based on current evidence. Journal of Clinical Medicine. 2020; 9(4):967. [DOI:10.3390/jcm9040967] [PMID] [PMCID]
Pung R, Chiew CJ, Young BE, Chin S, Chen MIC, Clapham HE, et al. Investigation of three clusters of COVID-19 in Singapore: Implications for surveillance and response measures. The Lancet. 2020; 395(10229):1039-46. [DOI:10.1016/S0140-6736(20)30528-6] [PMID] [PMCID]
Godaert L, Proye E, Demoustier-Tampere D, Coulibaly PS, Hequet F, Dramé M. Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France. The Journal of Infection. 2020; 81(1):E93-4. [DOI:10.1016/j.jinf.2020.04.009] [PMID] [PMCID]
Cruz AT, Zeichner SL. COVID-19 in children: Initial characterization of the pediatric disease. Pediatrics. 2020; 145(6):e20200834. [DOI:10.1542/peds.2020-0834] [PMID]
Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020; 8(5):475-81. [DOI:10.1016/S2213-2600(20)30079-5]
Zhou W, Liu Y, Tian D, Wang Ch, Wang S, Cheng J, et al. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia. Signal Transduction and Targeted Therapy. 2020; 5:18. [DOI:10.1038/s41392-020-0127-9] [PMID] [PMCID]
Cipollaro L, Giordano L, Padulo J, Oliva F, Maffulli N. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. Journal of Orthopaedic Surgery and Research. 2020; 15:178. [DOI:10.1186/s13018-020-01702-w] [PMID] [PMCID]
Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China. Journal of Medical Virology. 2020; 92(4):441-7. [DOI:10.1002/jmv.25689] [PMID] [PMCID]
Fan E. Critical illness neuromyopathy and the role of physical therapy and rehabilitation in critically ill patients. Respiratory Care. 2012; 57(6):933-46. [DOI:10.4187/respcare.01634] [PMID]
Ambrosino N, Makhabah DN. Comprehensive physiotherapy management in ARDS. Minerva Anestesiologica. 2013; 79(5):554-63. [PMID]
Lau HMC, Ng GYF, Jones AYM, Lee EWC, Siu EHK, Hui DSC. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Australian Journal of Physiotherapy. 2005; 51(4):213-9. [DOI:10.1016/S0004-9514(05)70002-7]
Ma J, Yin J, Qian Y, Wu Y. Clinical characteristics and prognosis in cancer patients with COVID-19: A single center’s retrospective study. Journal of Infection. 2020; 81(2):318-56. [DOI:10.1016/j.jinf.2020.04.006] [PMID] [PMCID]
Zheng Y, Xu H, Yang M, Zeng Y, Chen H, Liu R, et al. Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu. Journal of Clinical Virology. 2020; 127:104366. [DOI:10.1016/j.jcv.2020.104366] [PMID] [PMCID]
Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory coronavirus disease 2019 in Wuhan, China. Clinical Infectious Diseases. 2020; March:ciaa270. [DOI:10.1093/cid/ciaa270] [PMID] [PMCID]
Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020; 69(6):1002-9. [DOI:10.1136/gutjnl-2020-320926] [PMID] [PMCID]
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. 2020; 382(18):1708-20. [DOI:10.1056/NEJMoa2002032] [PMID] [PMCID]
Escalera-Antezana JP, Lizon-Ferrufino NF, Maldonado-Alanoca A, Alarcón-De-la-Vega G, Alvarado-Arnez LE, Balderrama-Saavedra MA, et al. Clinical features of the first cases and a cluster of coronavirus disease 2019 (COVID-19) in Bolivia imported from Italy and Spain. Travel Medicine and Infectious Disease. 2020; 35:101653. [DOI:10.1016/j.tmaid.2020.101653] [PMID] [PMCID]
Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study. European Archives of Oto-Rhino-Laryngology. 2020; 277(8):2251-61. [DOI:10.1007/s00405-020-05965-1] [PMID] [PMCID]
Tian S, Hu N, Lou J, Chen K, Kang X, Xiang Zh, et al. Characteristics of COVID-19 infection in Beijing. Journal of Infection. 2020; 80(4):401-6. [DOI:10.1016/j.jinf.2020.02.018] [PMID] [PMCID]
Dreher M, Kersten A, Bickenbach J, Balfanz P, Hartmann B, Cornelissen C, et al. The characteristics of 50 hospitalized COVID-19 patients with and without ARDS. Deutsches Ärzteblatt International. 2020; 117(16):271-8. [DOI:10.3238/arztebl.2020.0271] [PMID] [PMCID]
Huang Ch, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223):497-506. [DOI:10.1016/S0140-6736(20)30183-5]
Tuzun S, Keles A, Okutan D, Yildiran T, Palamar D. Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19 [Internet]. 2020 [Updated 2020 August 13]. Available from: https://www.researchsquare.com/article/rs-56548/v1 [DOI:10.21203/rs.3.rs-56548/v1]
Hoong CWS, Amin MNME, Tan TC, Lee JE. Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms. International Journal of Infectious Diseases. 2021; 104:363-9. [DOI:10.1016/j.ijid.2021.01.031] [PMID] [PMCID]
van Steenbergen HW, da Silva JAP, Huizinga TWJ, van der Helm-van AHM. Preventing progression from arthralgia to arthritis: Targeting the right patients. Nature Reviews Rheumatology. 2018; 14(1):32-41. [DOI:10.1038/nrrheum.2017.185] [PMID] [PMCID]
Hsia W. Emerging new coronavirus infection in Wuhan, China: Situation in early 2020. Case Study and Case Report. 2020; 10(1):8-9. https://drive.google.com/file/d/1QHDc5y3WWRXpGQqcVFLofeN25xZdzL8X/view
Wang D, Hu B, Hu Ch, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-9. [DOI:10.1001/jama.2020.1585] [PMID] [PMCID]
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet. 2020; 395(10223):507-13. [DOI:10.1016/S0140-6736(20)30211-7]
Yasri S, Wiwanitkit V. Editorial: Wuhan coronavirus outbreak and imported case. Advance Tropical Medicine and Public Health International. 2020; 10:1-2. https://drive.google.com/file/d/1n05KC205S6x2PAtzatmsWK6fMOemaEBv/view
Joob B, Wiwanitkit V. Arthralgia as an initial presentation of COVID-19: Observation. Rheumatology International. 2020; 40:823. [DOI:10.1007/s00296-020-04561-0] [PMID] [PMCID]
Lippi G, Wong J, Henry BM. Myalgia may not be associated with severity of coronavirus disease 2019 (COVID-19). World Journal of Emergency Medicine. 2020; 11(3):193-4. [DOI:10.5847/wjem.j.1920-8642.2020.03.013] [PMID] [PMCID]
Kucuk A, Cure MC, Cure E. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clinical Rheumatology. 2020; 39(7):2103-4. [DOI:10.1007/s10067-020-05178-1] [PMID] [PMCID]
Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology. 2004; 203(2):631-7. [DOI:10.1002/path.1570] [PMID] [PMCID]
Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-Converting Enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Medicine. 2020; 46(4):586-90. [DOI:10.1007/s00134-020-05985-9] [PMID] [PMCID]
Cure E, Cure MC. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020; 14(4):349-50. [DOI:10.1016/j.dsx.2020.04.019] [PMID] [PMCID]
Cure E, Cure MC. Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020; 14(4):405-6. [DOI:10.1016/j.dsx.2020.04.024] [PMID] [PMCID]
Juel C, Halestrap AP. Lactate transport in skeletal muscle-role and regulation of the monocarboxylate transporter. The Journal of Physiology. 1999; 517(3):633-42. [DOI:10.1111/j.1469-7793.1999.0633s.x] [PMID] [PMCID]
Queme LF, Ross JL, Jankowski MP. Peripheral mechanisms of ischemic myalgia. Frontiers in Cellular Neuroscience. 2017; 11:419. [DOI:10.3389/fncel.2017.00419] [PMID] [PMCID]
Alharbi J, Jackson D, Usher K. The potential for COVID‐19 to contribute to compassion fatigue in critical care nurses. Journal of Clinical Nursing. 2020; 29(15-16):2762-4. [DOI:10.1111/jocn.15314] [PMID] [PMCID]
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet. 2020; 395(10229):1054-62. [DOI:10.1016/S0140-6736(20)30566-3]
Moghadas SM, Shoukat A, Fitzpatrick MC, Wells CR, Sah P, Pandey A, et al. Projecting hospital utilization during the COVID-19 outbreaks in the United States. Proceedings of the National Academy of Sciences. 2020; 117(16):9122-6. [DOI:10.1073/pnas.2004064117] [PMID] [PMCID]
Saricaoglu EM, Hasanoglu I, Guner R. The first reactive arthritis case associated with COVID‐19. Journal of Medical Virology. 2021; 93(1):192-3. [DOI:10.1002/jmv.26296]
| Files | ||
| Issue | Vol 15 No 4 (2021) | |
| Section | Review Article(s) | |
| DOI | https://doi.org/10.18502/jmr.v15i4.7742 | |
| Keywords | ||
| Musculoskeletal pain Myalgia Arthralgia Fatigue COVID-19 | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
